主办:上海医药工业研究院
   中国药学会
   中国化学制药工业协会
ISSN 1001-8255   CN 31-1243/R   ZYGZEA

Archive

  • Select all
    |
    Perspectives & Review
  • Perspectives & Review
    WANG Xiaoxiao, WANG Junji, ZHAO Yuan, HE Jun*, LU Weigen
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Quality by design (QbD) is a systematic, structured, science- and risk-based approach for drug development. It is an important tool for the scientific and effective management of products, processes, and analytical methods. As a novel microparticle drug delivery system, liposomes can be administered through multiple routes, with good sustained-release profile and biocompatibility. However, the liposome formulation and process are complicated and difficult to develop. This paper summarizes the formulation and process factors in the development of liposomal products based on an understanding of the FDA's 2018 guidelines for liposome drug products. The research and development examples of liposome drugs based on QbD concept at home and abroad are introduced, and the specific process of liposome drug development with QbD concept is reviewed. And the application of QbD will provide guidance on the development of liposome drug products in the future.
  • Perspectives & Review
    JIN Yuqiong, QIU Yuan, CAO Kun, HE Fen*
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    There is a progressive evolution in the use of inhalable drug delivery systems for lung cancer therapy. The inhalation route offers many advantages, being non-invasive method of drug administration as well as localized delivery of anti-cancer drugs to tumor tissue. Pulmonary delivery of chemotherapy via inhalable nanocarriers has gained more attention in recent years due to their ability to improve solubility of poorly soluble drugs and keep their sustainedrelease, in addition to their ability to target cancer tissues in the lungs. Moreover, nanocarriers can be taken up into the cancer cells via endocytosis, leading to improved anti-tumor activity compared with the free drug. This article reviews various inhalable colloidal systems studied for tumor-targeted drug delivery including polymeric, lipid and hybrid nanocarriers. Actively targeted nanoparticles could be developed via surface modification to enhance nanoparticles accumulation into lung cancer cells via receptor-mediated endocytosis. Various active targeting approaches sorted based on cellular target are also illustrated.
  • Paper
  • Paper
    WANG Xiaoru, TIAN Xiaorong, CHEN Shaoxin*
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Epirubicin, an important anthracycline-type antitumor drug, is industrially produced through a chemical semisynthetic process. The production of epirubicin by genetic engineering microorganism directly is a more sustainable alternative. But its yield was below 1 mg/L in previous studies. Here the epirubicin was formed by introducing heterologous Streptomyces avermitilis aveBIV gene into high-doxorubicin producing S. peucetius SIPI-11 dnmV mutant blocked in the biosynthesis of daunosamine, the deoxysugar component of doxorubicin, and a recombinant strain EPI- 1 was constructed. The recombinant strain EPI-1 produced 47 mg/L epirubicin, which was more than 47-fold higher than the engineered strain ever reported, indicating using overproduction strains as hosts is an efficient way to enhance epirubicin yield. Furthermore, to increase the yield of epirubicin in recombinant S. peucetius, we overexpressed the related genes of daunosamine formation and glycosylation in the epirubicin biosynthesis pathway. The engineered strain EPI-2 produced 95 mg/L epirubicin, which increased by 102% compared with EPI-1, which also demonstrated that daunosamine formation and glycosylation were the rate-limiting steps in the biosynthesis of epirubicin. Finally, the EPI-2 was cultured in a 5 L fermenter, and the maximum titer of epirubicin reached 110 mg/L at 168 h. The results showed that S. peucetius EPI-2 has potential industrial application in epirubicin production by one-step fermentation.
  • Paper
    WU Suzhen, BAO Guanglong, ZHANG Naihua, CHEN Chengfu, ZHANG Guimin*
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    The synthetic process of dexrabeprazole sodium was improved. 2-(Hydroxymethyl)-4-(3- methoxypropoxy)-3-methylpyridine hydrochloride reacted with sulfoxide chloride to give 2-(chloromethyl)-4- (3-methoxypropoxy)-3-methylpyridine hydrochloride, and then the aqueous solution without purification was directly subjected to a substitution with 2-mercaptobenzimidazole in H2O/acetone at room temperature. Then 2-[[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl]thio]-1H-benzo[d]imidazole was obtained by simply workup with a yield of 93.7%. The latter was subjected to an asymmetric oxidation using tetra isopropyl titanate and diethyl L-tartrate as the chiral catalysts, hydroperoxide,bis(1-methylethyl)phenyl as the oxidant to afford dexrabeprazole with a purity of 99.9% after three refining steps. Finally, the target product was prepared via a salification with sodium hydroxide in an overall yield of 83.0%, a purity of 99.9%, and a chiral purity of 99.9%. This optimized process has mild reaction conditions and simple operation, and it has been tested in pilot scale.
  • Paper
    YANG Chuanwei1, LIU Jie1, LIU Wentao2, LI Xinzhi1, WU Shide1*
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    An improvement process of tadalafil synthesis in kilogram scale was reported. D-tryptophan was subjected to esterification to give methyl (2R)-2-amino-3-(1H-indol-3-yl)propanoate hydrochloride, which was followed by a Pictet-Spengler reaction with heliotropin in acetonitrile/isopropanol to provide methyl (1R,3R)-1,2,3,4-tetrahydro- 1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate hydrochloride. In this step, the reaction time was shortened from 16~18 h to 10 h, and the product was obtained by heat filtration and then cleaned by acetonitrile with a yield of 98.5%. The latter reacted with chloroacetyl chloride in dichloromethane to produce methyl (1R,3R)-1,2,3,4- tetrahydro-2-(2-chloroacetyl)-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate , then the latter was subjected to a cyclization with methylamine in ethanol to produce the target compound with an overall yield of 79%, and a purity of 99.9%. This improved process has the advantages of mild reaction conditions and simple operation, which is suitable for industrial production.
  • Paper
    HUANG Wenfeng, ZHANG Jian, HU Jiaxing, YU Wenlong*
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    The synthesis of 6-fluoro-3-(piperidin-4-yl)-1,2-benzoisoxazole hydrochloride, a key intermediate of risperidone was improved. (2,4-Difluorophenyl)(piperidin-4-yl)methanone hydrochloride reacted with hydroxylamine hydrochloride in ethanol/H2O at reflux for 12 h to afford (Z)-(2,4-difluorophenyl)(piperidin-4-yl)-methanone oxime with a yield of 97%. Then the latter was subjected to an intramolecular nucleophilic substitution with KOH in toluene/ H2O followed by a salification to produce the target compound. The result showed that, the content of dimer impurity in the final product could be reduced to 1% by using two-phase solvent (toluene/H2O). The improved process has some advantages such as simple operation, high total yield (about 80%) with a purity of 99%, which is suitable for industrial production.
  • Paper
    CHEN Hua1,2, YANG Sen3, YAO Kai1,2, LI Jianqi1,2, LIU Yu1,2*
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    The synthesis of (1-chloroethyl) N-methyl-N-[3-[[(N-tert-butoxycarbonyl-N-methylamino)- acetoxy]methyl]pyridin-2-yl]carbamate, the key intermediate of isavuconazonium sulfate was improved. 2-Chloronicotinic acid reacted with oxaloyl chloride to give 2-chloronicotinoyl chloride, which was followed by esterification and substitution to afford tert-butyl 2-(methylamino)nicotinate. Then the latter was subjected to reduction by borane to produce [2-(methylamino)pyridin-3-yl]methanol (6). Finally, the target compound was obtained via a condensation of 6 with 1-chloroethyl chloroformate and N-(tert-butoxycarbonyl)sarcosine in acetone at room temperature by using sodium bicarbonate instead of diisopropylamine. The improved reaction conditions were mild and easy to operate, the total yield was 64.2%.
  • Paper
    GU Xuding1, WANG Fujun1*, PU Tong2, SONG Qingbao3, LIU Yukun1
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Recombinant Escherichia coli was adopted to express (R)-carbonyl reductase, and the induction temperature, carbon source type and feeding speed were optimized for the best producation of (R)-carbonyl reductase. The optimum conditions for enzyme production were as follows: temperature: 28 ℃, glucose as the carbon source and feeding rate: 20 ml/h. Under these conditions, the activity of (R)-carbonyl reductase was increased to 63.1 U/g. The key intermediate of nepirolol, (R)-2-chloro-1-[(R)-6-fluorochroman-2-yl]ethan-1-ol was synthesized in the presence of glucose dehydrogenase coupled with (R)-carbonyl reductase. When the dosage of 2-chloro-1-[(R)-6-fluorochroman- 2-yl]ethan-1-one was 5 g, the optimal dosage of glucose dehydrogenase and (R)-carbonyl reductase were 1 000 U and 120 U respectively, the target compound was prepared with a yield of 91%, a purity of 98.3%, chiral HPLC purity of 99.6%, and chiral GC purity of 98.5%.
  • Paper
    XIA Xu, GAO Wenyan, LIU Xiaoya, SHEN Chen, YE Jincui*
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    To explore the permeation enhancement effect of microneedle-assisted transdermal drug delivery, the in vitro drug skin penetration through guinea pig skin and the in vivo pharmacokinetics in Beagle dogs were investigated by the combined use of self-made ramosetron hydrochloride patches and microneedles by which the skin was pre-treated before application of the patches. The Valia-Chien double chamber permeation pool was applied to carry out the skin permeation test with excised guinea pig skin as the barrier. The results of in vitro skin permeation experiment showed that, the steady-state permeation rate and the cumulative permeation amount at 48 h in microneedle-assisted transdermal patch group were 1.68 times and 1.80 times greater than those in the only patch group, and the lag time of transdermal permeation was significantly shorter than that of the permeation through the skin without microneedle pretreatment (P<0.01). Pharmacokinetic results in Beagle dogs showed that, the cmax and AUC0→t of the microneedle-assisted group were 4.8 times and 4.6 times higher than those of the control group (P<0.01). The tmax of microneedle-assisted group was also significantly shorter than the control group (P<0.01 , 6.2 h vs 30.7 h). The comprehensive evaluation of in vitro permeation test and in vivo pharmacokinetic fully showed that microneedle-assisted transdermal administration had a significant effect on promoting the absorption of drugs and shortening the lag time of permeation.
  • Paper
    ZHANG Hanying, DONG Xiaotao, CHEN Jili, WU Fei, JIN Tuo*
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    Microneedle transdermal patches represent the most promising dosage form for efficient and accurate non-injecting administration of biological medicine to date. Although microneedles only penetrate the epidermis and release drugs at the dermis layer without invading the body and causing skin injury, it is still regarded as injections in administrative approval. Developing a feasible sterilization method is therefore of great importance. Phase transition microneedle is formed of mixed hydrophilic polymers with polyvinyl alcohol (PVA) as the majority. After insertion into skin, the patch would absorb body fluid and convert to swollen hydrogel state enabling pre-loaded drug to be released from matrix of microneedles. Since bacteria and viral particles are several orders of magnitude larger than proteins in diameter and cannot be released from the network of the swollen matrix of microneedles, sterilization could be achieved more easily. To address the inability of sterilizing protein drugs by steaming and heating, the present study was aimed to investigate the feasibility of incubating microneedle patches in ethylene oxide atmosphere at relative mild temperature. The insulin lispro microneedle patches were treated in an ethylene oxide vapor of -30.3 kPa at 50 ℃, with relative humidity of 57.5%, for 2 h, followed by measurement of insulin lispro content changes by HPLC. There was no significant difference between sterile microneedles and non-sterile microneedles, meaning ethylene oxide would not have influence on drug content in microneedles. The treated microneedle patches were inoculated to culture medium for 14 d to examine the efficiency of the sterilization, and found no bacterium growth, suggesting the feasibility of the ethylene oxide steaming sterilization.
  • Paper
    YU Mingjie, XIANG Rongfeng, DAI Qing, XIONG Lirong, CHEN Yongchuan*
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    A LC-MS/MS method was established for the determination of mosapride citrate in Beagle dogs' plasma, so as to compare the pharmacokinetics of mosapride citrate sustained-release tablets and common tablets after single oral dose administration. Carbamazepine was used as the internal standard, and the samples were extracted with ethyl acetate in alkaline condition. An electrospray ionization (ESI+) source was applied and operated in the multiple reaction monitoring (MRM) mode, with the transitions of m/z 422.3→m/z 198.0(mosapride) and m/z 237.1→m/z 194.2(carbamazepine). It was linear for mosapride in the range of 0.4-40 ng/ml, and the extraction recovery was 73.0%-93.1%. The inter- and intra-day RSDs as well as the matrix effect RSDs were all less than 15%. In accordance with a randomized two-period self crossover study, six Beagle dogs were given single oral doses of the sustained-release tablets and common tablets, and the pharmacokinetic parameters were determined as follows: AUC0→t (24.067±6.245) and (26.035±6.717) ng·h·ml-1, cmax (6.175±1.091) and (12.636±3.810) ng·ml-1, tmax (2.583±0.376) and (0.750±0.204) h. The results showed that, cmax of the sustained-release tablets was significantly lower than that of the common tablets, and tmax of the sustained-release tablets was significantly longer than that of the common tablets. It suggests that mosapride citrate sustained-release tablets have an obvious characteristic of sustained release.
  • Paper
    YE Xiaoxia, WU Jingwen, LE Jian, YANG Yongjian*
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    A GC-MS/MS method was established for the determination of a genotoxic impurity bromoethane in tenofovir disoproxil fumarate. Samples were separated by DB-5MS column, and determined by tandem mass spectrometry in MRM mode. It was linear in the range of 54.01-756.20 ng/ml. The limit of determination was 14.74 ng/ml. The recovery was 96.7% with RSD of 3.43%. Due to the high specificity, this method could be used to detect bromoethane in tenofovir disoproxil fumarate product.
  • Paper
    LI Fang, FENG Zhen, LIU Dongling, LIU Hao, YANG Meicheng*
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    The microbial limit test method of Anshenbuxin preparations was established, and the test results of 193 products from 25 manufacturers were analyzed. Furthermore, certain contaminant bacteria of some batches were separated, isolated and identified. Bacterial counts were determined by neutralization dilution method, mold and yeast counts using neutralization method, as well as detection of Escherichia coli. The conventional methods were used for detection of Salmonella. A total of 37 microorganisms were collected, and the strains were identified by Gram stain, biochemical identification and RiboPrinter ribosome typing. The pass rate of microbial examination of 193 products was 100%. But there were different levels of microbial contamination. The main pollutants were Bacillus subtilis, Bacillus megaterium, Bacillus licheniformis and Bacillus cereus. The microbiological quality analysis of traditional Chinese medicine preparations should include the separation, identification and analysis of the detected microorganisms, which contributes to the quality control and process supervision of the products.
  • Paper
    NIE Shaoyong
    Abstract ( ) Download PDF ( )   Knowledge map   Save
    In pharmaceutical industry, water content was usually used to control chemical, physical, and microbiological properties of pharmaceutical product. Water content is usually measured by Karl Fischer(KF) titration. However, there is no significant correlation between water content and the chemical, physical, and microbiological properties of pharmaceutical product. Actually, water activity measurement provides a better correlation of water with the changes in chemical, physical, and microbiological properties than KF technique. In pharmaceutical industry, water activity was overlooked due to late regulatory obligation for pharmaceutical industry. The United States Pharmacopoeia and the European Pharmacopoeia published official chapter and/or section of water activity in the year 2006(29th Edition) and 2011(7th Edition), respectively. ICH Guidelines use word “dryness” in the sections about the control of microbiological growth, and the stability testing is required to hold in different humidity levels. All of these requirements relate with water activity. Therefore, application of water activity in pharmaceutical industry could improve the quality of pharmaceutical product significantly. Water activity measurements are nondestructive, require little labor and time, and the equipment required is generally inexpensive. Overall, water activity is very helpful for pharmaceutical research and development, control of the manufacturing environment, selection of packaging material, and the storage of pharmaceutical product and so on.
  • Pharmaceutical Management & Information
  • Pharmaceutical Management & Information
    XIONG Jiamei1,2, JIN Jing1,2, YANG Yue1,2, DONG Jiangping3*
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    DONG Shuangtao1, YIN Nan2, MA Zheng3*
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    MAO Ningying, MA Dandan
    Abstract ( ) Download PDF ( )   Knowledge map   Save
  • Pharmaceutical Management & Information
    CHEN Yun1,2, ZOU Yixuan1, SHAO Rong2, ZHOU Bin1*
    Abstract ( ) Download PDF ( )   Knowledge map   Save